Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(16):1-167. Epub 2005 Oct 1.

2.

Evaluation of ischemic heart disease.

Shah DJ, Kim HW, Kim RJ.

Heart Fail Clin. 2009 Jul;5(3):315-32, v. doi: 10.1016/j.hfc.2009.02.001. Review.

3.

Cardiac positron emission tomography: current clinical practice.

Lalonde L, Ziadi MC, Beanlands R.

Cardiol Clin. 2009 May;27(2):237-55, Table of Contents. doi: 10.1016/j.ccl.2008.12.003. Review.

PMID:
19306767
4.

Cardiac magnetic resonance evaluation of myocardial viability and ischemia.

Strzelczyk J, Attili A.

Semin Roentgenol. 2008 Jul;43(3):193-203. doi: 10.1053/j.ro.2008.02.005. Review. No abstract available.

PMID:
18486681
5.

Myocardial deformation imaging based on ultrasonic pixel tracking to identify reversible myocardial dysfunction.

Becker M, Lenzen A, Ocklenburg C, Stempel K, Kühl H, Neizel M, Katoh M, Kramann R, Wildberger J, Kelm M, Hoffmann R.

J Am Coll Cardiol. 2008 Apr 15;51(15):1473-81. doi: 10.1016/j.jacc.2007.10.066.

6.

Assessment of myocardial viability: comparison of echocardiography versus cardiac magnetic resonance imaging in the current era.

Tomlinson DR, Becher H, Selvanayagam JB.

Heart Lung Circ. 2008 Jun;17(3):173-85. doi: 10.1016/j.hlc.2007.10.005. Epub 2008 Jan 28. Review.

PMID:
18222726
7.

Hibernating myocardium: diagnosis and patient outcomes.

Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH.

Curr Probl Cardiol. 2007 Jul;32(7):375-410. Review.

PMID:
17560992
8.

New technology for noninvasive evaluation of coronary artery disease.

Di Carli MF, Hachamovitch R.

Circulation. 2007 Mar 20;115(11):1464-80. Review. No abstract available.

9.

CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary.

Beanlands RS, Chow BJ, Dick A, Friedrich MG, Gulenchyn KY, Kiess M, Leong-Poi H, Miller RM, Nichol G, Freeman M, Bogaty P, Honos G, Hudon G, Wisenberg G, Van Berkom J, Williams K, Yoshinaga K, Graham J; Canadian Cardiovascular Society; Canadian Association of Radiologists; Canadian Association of Nuclear Medicine; Canadian Nuclear Cardiology Society; Canadian Society of Cardiac Magnetic Resonance.

Can J Cardiol. 2007 Feb;23(2):107-19.

10.

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.

Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM.

BMC Med Res Methodol. 2007 Feb 15;7:10.

11.

Diagnostic and imaging considerations: role of viability.

Senior R.

Heart Fail Rev. 2006 Jun;11(2):125-34. Review.

PMID:
16937031
12.

Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.

Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Irwan R, Sluiter WJ, Dierckx RA, de Boer J, Jager PL.

Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):716-23. Epub 2006 Mar 8.

PMID:
16523309
13.
14.

PET imaging in cardiology.

Chacko GN.

Hell J Nucl Med. 2005 Sep-Dec;8(3):140-4. Review.

PMID:
16390017
15.

Regional variation in self-reported heart disease prevalence in Canada.

Chow CM, Donovan L, Manuel D, Johansen H, Tu JV; Canadian Cardiovascular Outcomes Research Team.

Can J Cardiol. 2005 Dec;21(14):1265-71.

PMID:
16341294
16.

Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment.

Selvanayagam JB, Jerosch-Herold M, Porto I, Sheridan D, Cheng AS, Petersen SE, Searle N, Channon KM, Banning AP, Neubauer S.

Circulation. 2005 Nov 22;112(21):3289-96. Epub 2005 Nov 14.

17.

Assessment of myocardial viability in chronic ischemic heart disease: current status.

Rizzello V, Poldermans D, Bax JJ.

Q J Nucl Med Mol Imaging. 2005 Mar;49(1):81-96. Review.

18.

Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.

Ghesani M, Depuey EG, Rozanski A.

Echocardiography. 2005 Feb;22(2):165-77. Review.

PMID:
15693785
19.

Clinical assessment of myocardial hibernation.

Schinkel AF, Bax JJ, Poldermans D.

Heart. 2005 Jan;91(1):111-7. Review. No abstract available.

20.

Radionuclide techniques for the assessment of myocardial viability and hibernation.

Bax JJ, van der Wall EE, Harbinson M.

Heart. 2004 Aug;90 Suppl 5:v26-33. Review. No abstract available.

Supplemental Content

Support Center